4mf3: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Crystal Structure of Human GRIK1 complexed with a 6-(tetrazolyl)aryl decahydroisoquinoline antagonist==
==Crystal Structure of Human GRIK1 complexed with a 6-(tetrazolyl)aryl decahydroisoquinoline antagonist==
<StructureSection load='4mf3' size='340' side='right' caption='[[4mf3]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
<StructureSection load='4mf3' size='340' side='right'caption='[[4mf3]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4mf3]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MF3 OCA]. <br>
<table><tr><td colspan='2'>[[4mf3]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MF3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4MF3 FirstGlance]. <br>
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SXI:(3S,4AS,6S,8AR)-6-[3-CHLORO-2-(1H-TETRAZOL-5-YL)PHENOXY]DECAHYDROISOQUINOLINE-3-CARBOXYLIC+ACID'>SXI</scene><br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3&#8491;</td></tr>
<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glucokinase Glucokinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 2.7.1.2] </span></td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SXI:(3S,4AS,6S,8AR)-6-[3-CHLORO-2-(1H-TETRAZOL-5-YL)PHENOXY]DECAHYDROISOQUINOLINE-3-CARBOXYLIC+ACID'>SXI</scene></td></tr>
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4mf3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mf3 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4mf3 RCSB], [http://www.ebi.ac.uk/pdbsum/4mf3 PDBsum]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4mf3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mf3 OCA], [https://pdbe.org/4mf3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4mf3 RCSB], [https://www.ebi.ac.uk/pdbsum/4mf3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4mf3 ProSAT]</span></td></tr>
<table>
</table>
== Function ==
[https://www.uniprot.org/uniprot/GRIK1_HUMAN GRIK1_HUMAN] Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. May be involved in the transmission of light information from the retina to the hypothalamus.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 13: Line 16:
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.,Martinez-Perez JA, Iyengar S, Shannon HE, Bleakman D, Alt A, Clawson DK, Arnold BM, Bell MG, Bleisch TJ, Castano AM, Del Prado M, Dominguez E, Escribano AM, Filla SA, Ho KH, Hudziak KJ, Jones CK, Mateo A, Mathes BM, Mattiuz EL, Ogden AM, Simmons RM, Stack DR, Stratford RE, Winter MA, Wu Z, Ornstein PL Bioorg Med Chem Lett. 2013 Dec 1;23(23):6463-6. doi: 10.1016/j.bmcl.2013.09.045. , Epub 2013 Sep 24. PMID:24140446<ref>PMID:24140446</ref>
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.,Martinez-Perez JA, Iyengar S, Shannon HE, Bleakman D, Alt A, Clawson DK, Arnold BM, Bell MG, Bleisch TJ, Castano AM, Del Prado M, Dominguez E, Escribano AM, Filla SA, Ho KH, Hudziak KJ, Jones CK, Mateo A, Mathes BM, Mattiuz EL, Ogden AM, Simmons RM, Stack DR, Stratford RE, Winter MA, Wu Z, Ornstein PL Bioorg Med Chem Lett. 2013 Dec 1;23(23):6463-6. doi: 10.1016/j.bmcl.2013.09.045. , Epub 2013 Sep 24. PMID:24140446<ref>PMID:24140446</ref>


From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
</div>
<div class="pdbe-citations 4mf3" style="background-color:#fffaf0;"></div>
==See Also==
*[[Glutamate receptor 3D structures|Glutamate receptor 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Alt, A.]]
[[Category: Homo sapiens]]
[[Category: Arnold, B M.]]
[[Category: Large Structures]]
[[Category: Bell, M G.]]
[[Category: Alt A]]
[[Category: Bleakman, D.]]
[[Category: Arnold BM]]
[[Category: Bleisch, T J.]]
[[Category: Bell MG]]
[[Category: Castano, A M.]]
[[Category: Bleakman D]]
[[Category: Clawson, D K.]]
[[Category: Bleisch TJ]]
[[Category: Dominguez, E.]]
[[Category: Castano AM]]
[[Category: Escribano, A M.]]
[[Category: Clawson DK]]
[[Category: Filla, S A.]]
[[Category: Del Prado M]]
[[Category: Ho, K H.]]
[[Category: Dominguez E]]
[[Category: Hudziak, K J.]]
[[Category: Escribano AM]]
[[Category: Iyengar, S.]]
[[Category: Filla SA]]
[[Category: Jones, C K.]]
[[Category: Ho KH]]
[[Category: Katofiasc, M A.]]
[[Category: Hudziak KJ]]
[[Category: Martinez-Perez, J A.]]
[[Category: Iyengar S]]
[[Category: Mateo, A.]]
[[Category: Jones CK]]
[[Category: Mathes, B M.]]
[[Category: Katofiasc MA]]
[[Category: Mattiuz, E L.]]
[[Category: Martinez-Perez JA]]
[[Category: Ogden, A M.L.]]
[[Category: Mateo A]]
[[Category: Ornstein, P L.]]
[[Category: Mathes BM]]
[[Category: Phebus, L A.]]
[[Category: Mattiuz EL]]
[[Category: Prado, M Del.]]
[[Category: Ogden AML]]
[[Category: Shannon, H E.]]
[[Category: Ornstein PL]]
[[Category: Simmons, R M.A.]]
[[Category: Phebus LA]]
[[Category: Stack, D R.]]
[[Category: Shannon HE]]
[[Category: Stratford, R E.]]
[[Category: Simmons RMA]]
[[Category: Winter, M A.]]
[[Category: Stack DR]]
[[Category: Wu, Z.]]
[[Category: Stratford RE]]
[[Category: Glutamate binding]]
[[Category: Winter MA]]
[[Category: Glutamate receptor]]
[[Category: Wu Z]]
[[Category: Ligand gated ion channel]]
[[Category: Membrane]]
[[Category: None]]
[[Category: Protein-ligand complex]]
[[Category: Signaling protein]]

Latest revision as of 11:09, 6 November 2024

Crystal Structure of Human GRIK1 complexed with a 6-(tetrazolyl)aryl decahydroisoquinoline antagonist

4mf3, resolution 3.00Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA